CCP
NUVA

Clough Capital Partners’s NuVasive, Inc. NUVA Stock Holding History

Clough Capital Partners’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-149,300
Closed -$11.5M – 146
2017
Q2 		$11.5M Buy
+149,300
New +$11.2M 0.8% 43

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Clough Capital Partners's NUVA Position: Q3 2017 in Review

Clough Capital Partners sold out of NuVasive, Inc. (NUVA) in Q3 2017, closing a stake of 149,300 shares — an estimated $11.5M sold.

Clough Capital Partners first reported a position in NUVA in Q2 2017 and held it in 1 quarter. The position peaked at $11.5M in Q2 2017. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2017.

  • Clough Capital Partners reported no remaining NuVasive, Inc. position as of Q3 2017 after selling out during the quarter.
  • Clough Capital Partners sold 149,300 NuVasive, Inc. shares in Q3 2017, an estimated $11.5M.
  • Clough Capital Partners first reported a position in NuVasive, Inc. in Q2 2017 and held it in 1 quarter.
  • Clough Capital Partners's NuVasive, Inc. position peaked at $11.5M in Q2 2017.
  • 263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2017.

Based on Clough Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.